Organon & Co. company mark

Organon & Co. Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: OGN
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Cap $3.56B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

Organon & Co. Business Intelligence Hub

The Organon & Co. Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on Organon & Co.. This page always opens the latest Business Intelligence annual report and stays in sync with Organon & Co.'s newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

Organon & Co. Financial Performance & Statements

Explore Organon & Co.'s financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

Organon & Co. Quarterly Earnings & Management Commentary

Read the latest Organon & Co. quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

Organon & Co. Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

Organon & Co. Sector, Valuation & Risk Analysis

See Organon & Co. in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: Organon & Co. annual report, Organon & Co. AI annual report, Organon & Co. fundamental analysis, Organon & Co. business analysis, Organon & Co. financial performance, Organon & Co. financial statements, Organon & Co. growth analysis, Organon & Co. management analysis, Organon & Co. corporate governance, Organon & Co. cash flow analysis, Organon & Co. business intelligence, Organon & Co. valuation, Organon & Co. quarterly results, Organon & Co. earnings summary, Organon & Co. management commentary, Organon & Co. sector analysis, Organon & Co. company research, Organon & Co. equity research, Organon & Co. stock analysis, Organon & Co. AI company analysis, Organon & Co. capital allocation, Organon & Co. risk analysis, Organon & Co. competitive position, Organon & Co. long-term growth.